Skip to main content
logo
Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
20.37
-0.03 (-0.15%)
At close: Aug 10, 2026, 4:00 PM EDT
20.30
-0.07 (-0.34%)
After-hours: Aug 10, 2026, 7:34 PM EDT

Syndax Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
252.25172.3523.68--139.71
Revenue Growth
222.65%627.84%---9109.56%
Gross Profit
241.6165.3822.85--139.71
Operating Income
-194.17-273.08-339.67-229.95-151.7626.22
Net Income
-220.77-285.42-318.76-209.36-149.3424.93
Earnings Per Share
-2.51-3.29-3.72-2.98-2.460.46
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
554.27413.69582.91577.58484.4446.83
Total Debt
245.361.522.061.641.1620.97
Net Cash (Debt)
308.91412.16580.86575.95483.24425.86
Net Cash Growth
-33.86%-29.04%0.85%19.19%13.47%56.26%
Net Cash Per Share
3.524.766.788.187.957.94

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-220.64-322.98-274.9-160.6-133.6829.13
Capital Expenditures
-0.19-0.19----0.13
Free Cash Flow
-220.83-323.17-274.9-160.6-133.6829
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
95.78%95.96%96.51%--100.00%
Operating Margin
-76.98%-158.45%-1434.43%--18.77%
Pretax Margin
-67.57%-172.76%-1257.79%--17.84%
Profit Margin
-87.52%-165.60%-1346.11%--17.84%
FCF Margin
-87.54%-187.50%-1160.91%--20.76%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----47.59
P/FCF Ratio
-----41.50
PS Ratio
7.2110.6547.84--8.61